a developer of innovative therapies for the treatment of acute and breakthrough pain
Industry PharmaceuticalsOther
A.I.dvisor tells us that TLPH and RDY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and RDY's prices will move in lockstep.
Ticker / NAME | Correlation To TLPH | 1D Price Change % | ||
---|---|---|---|---|
TLPH | 100% | -3.85% | ||
RDY - TLPH | 22% Poorly correlated | -2.84% | ||
COLL - TLPH | 16% Poorly correlated | -2.70% | ||
ALKS - TLPH | 12% Poorly correlated | -1.16% | ||
TEVA - TLPH | 9% Poorly correlated | -1.85% | ||
VTRS - TLPH | 9% Poorly correlated | -1.57% | ||
More |
Ticker / NAME | Correlation To TLPH | 1D Price Change % |
---|---|---|
TLPH | 100% | -3.85% |
pharmaceuticals theme (167 stocks) | 9% Poorly correlated | +0.82% |
pain theme (4 stocks) | 4% Poorly correlated | +1.89% |
Pharmaceuticals: Other theme (252 stocks) | -3% Poorly correlated | +0.05% |
Pharmaceuticals theme (328 stocks) | -6% Poorly correlated | +0.11% |